OCT imaging improves percutaneous coronary intervention, study finds

At the ESC Congress 2016 (August 27-31, 2016; Rome, Italy), the European Society of Cardiology's annual meeting, researchers at University Hospital Jean Minjoz (Besançon, France) demonstrated that optical coherence tomography (OCT) imaging can visualize the coronary arteries in patients undergoing percutaneous coronary intervention (PCI) and lead to better outcomes compared to standard angiography-guided PCI.

Related: Totally tubular: Cardiovascular OCT goes prime time

In patients with non-sinustachycardia (ST)-segment elevation acute coronary syndromes (NSTE-ACS), OCT provided useful additional information beyond that obtained by angiography alone, and impacted directly on physician decision-making, according to Nicolas Meneveau, MD, Ph.D, the Does Optical Coherence Tomography Optimize Results of Stenting (DOCTORS) study's lead investigator.

OCT, which involves introducing an imaging catheter into the coronary artery to check vessel size, lesion characteristics, and stent positioning, and expansion, led to a change in procedural strategy in half of cases, Meneveau says. However, additional prospective randomized studies with clinical endpoints are required before it can be recommended for standard use, he adds.

The multi-center DOCTORS study included 240 NSTE-ACS patients who were randomized 1:1 to standard fluoroscopy-guided PCI alone (angio group) and with the addition of OCT performed an average of 3.8 times before, during, and after the procedure. Overall, OCT was associated with better functional outcome than PCI guided by fluoroscopy alone, Meneveau says.

The primary endpoint of the study, which was fractional flow reserve (FFR; a measure of blood flow and pressure in the coronary artery before and after the procedure), was significantly better in the OCT group as compared to the angio group (0.94 vs. 0.92, p=0.005). In addition, the number of patients with a post-procedural FFR >0.90 was significantly higher in the OCT group (82.5% vs. 64.2%, p=0.0001).

Compared to angiography, OCT allowed clinicians to see significantly more thrombi (69% vs. 47%, p=0.0004) and calcifications (45.8% vs. 9%, p<0.0001) before stent implantation. This resulted in more frequent antiplatelet use in the OCT group (53.3% vs. 35.8%). OCT was also significantly more likely to reveal stent underexpansion (42% vs. 10.8%), incomplete lesion coverage (20% vs. 17%), and edge dissection (37.5% vs. 4%) compared to angiography. Stent malapposition, which is not visible under fluoroscopy alone, was observed in 32% of patients undergoing OCT.

These observations led to the more frequent use of post-stent overinflation in the OCT group  (43% vs. 12.5%, p<0.0001) and a lower percentage of residual stenosis (7.0% vs. 8.7%, p=0.01).

The addition of OCT increased procedure time as well as patients' exposure to fluoroscopy and contrast medium, but this did not increase complications such as peri-procedural myocardial infarction or impaired kidney function, Meneveau says. "The improvement in functional outcomes could translate into a clinical benefit in the longer term," he adds.

Details of the work also appear in the journal Circulation; for more information, please visit http://circ.ahajournals.org/content/early/2016/08/28/circulationaha.116.024393.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Microscopy system harnesses virtual reality technology for image-guided neurosurgery

A microscope image injection system overlays virtual reality imaging onto the brain when viewed through the eyepiece during surgery.

Wearable light therapy device for hair loss receives regulatory approval in Brazil

The iGrow hair growth system, a wearable low-level light therapy device for treating hair loss, is cleared for use in Brazil.

Method that speeds disease detection has potential for use with portable optical readers

A new method to speed and simplify detection of proteins in blood and plasma is promising for use with portable optical readers.

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS